Responses
Poster Presentation
Rheumatoid arthritis - non biologic treatment
THU0221 Methotrexate Optimization (IE Introduction During the First 3 Months and with Dose Escalation at 6 Months at Least at 20Mg/W or 0.3Mg/Kg/W) is Associated with Better Clinical Outcomes in Daily Practice: Results from the Espoir Cohort
Compose a Response to This Article
Other responses
No responses have been published for this article.